GR3031047T3 - Paroxetine tablets and process to prepare them - Google Patents

Paroxetine tablets and process to prepare them

Info

Publication number
GR3031047T3
GR3031047T3 GR990402125T GR990402125T GR3031047T3 GR 3031047 T3 GR3031047 T3 GR 3031047T3 GR 990402125 T GR990402125 T GR 990402125T GR 990402125 T GR990402125 T GR 990402125T GR 3031047 T3 GR3031047 T3 GR 3031047T3
Authority
GR
Greece
Prior art keywords
prepare
paroxetine tablets
paroxetine
tablets
Prior art date
Application number
GR990402125T
Other languages
English (en)
Inventor
Ram Dutta Pathak
David George Dr Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3031047(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of GR3031047T3 publication Critical patent/GR3031047T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR990402125T 1993-12-15 1999-08-19 Paroxetine tablets and process to prepare them GR3031047T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (1)

Publication Number Publication Date
GR3031047T3 true GR3031047T3 (en) 1999-12-31

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402125T GR3031047T3 (en) 1993-12-15 1999-08-19 Paroxetine tablets and process to prepare them

Country Status (36)

Country Link
US (1) US6113944A (el)
EP (1) EP0734260B2 (el)
JP (1) JP3037757B2 (el)
KR (1) KR100367796B1 (el)
CN (1) CN1071116C (el)
AP (1) AP540A (el)
AT (1) ATE180973T1 (el)
AU (1) AU697982B2 (el)
BG (1) BG62755B1 (el)
BR (1) BR9408219A (el)
CA (4) CA2178637C (el)
CZ (1) CZ287891B6 (el)
DE (1) DE69419033T2 (el)
DK (1) DK0734260T4 (el)
DZ (1) DZ1835A1 (el)
ES (1) ES2132610T5 (el)
FI (1) FI962445A0 (el)
GB (1) GB9325644D0 (el)
GR (1) GR3031047T3 (el)
HK (1) HK1012285A1 (el)
HU (1) HUT75880A (el)
IL (1) IL111978A (el)
MA (1) MA23395A1 (el)
MY (1) MY112123A (el)
NO (1) NO307366B1 (el)
NZ (1) NZ277790A (el)
OA (1) OA10297A (el)
PL (1) PL314980A1 (el)
RO (1) RO115413B1 (el)
RU (1) RU2146141C1 (el)
SA (1) SA94150373B1 (el)
SI (1) SI0734260T2 (el)
SK (1) SK282620B6 (el)
UA (1) UA42745C2 (el)
WO (1) WO1995016448A1 (el)
ZA (1) ZA949900B (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2293247C (en) 1997-06-10 2005-04-12 Synthon B.V. 4-phenylpiperidine compounds
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2418038A1 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
ES2280892T3 (es) 2001-07-31 2007-09-16 H. Lundbeck A/S Composicion cristalina que contiene escitalopram.
PT1440067E (pt) * 2001-10-22 2005-02-28 Synthon Bv Derivados n-formilo de paroxetina
EP1575478A2 (en) * 2001-12-28 2005-09-21 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
EP1761270A1 (en) * 2004-06-23 2007-03-14 Merck & Co., Inc. Estrogen receptor modulators
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
EP1948646A2 (en) * 2005-11-14 2008-07-30 Auspex Pharmaceuticals Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (el) * 1974-03-04 1975-09-11
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
IL111978A (en) 2000-07-16
CA2178637A1 (en) 1995-06-22
MA23395A1 (fr) 1995-07-01
DK0734260T3 (da) 1999-11-15
AU697982B2 (en) 1998-10-22
DE69419033D1 (de) 1999-07-15
HK1012285A1 (en) 1999-07-30
ZA949900B (en) 1995-10-10
NO962547L (no) 1996-06-14
SK282620B6 (sk) 2002-10-08
CZ176396A3 (en) 1996-09-11
JPH09506602A (ja) 1997-06-30
WO1995016448A1 (en) 1995-06-22
CA2274389C (en) 2004-09-14
CZ287891B6 (cs) 2001-03-14
AP540A (en) 1996-09-20
DK0734260T4 (da) 2008-09-29
ATE180973T1 (de) 1999-06-15
CA2214575C (en) 1999-12-07
SI0734260T2 (sl) 2008-12-31
MY112123A (en) 2001-04-30
DE69419033T2 (de) 1999-11-25
CN1137236A (zh) 1996-12-04
GB9325644D0 (en) 1994-02-16
CA2178637C (en) 1997-12-23
KR100367796B1 (ko) 2003-07-22
HU9601665D0 (en) 1996-08-28
US6113944A (en) 2000-09-05
EP0734260B1 (en) 1999-06-09
SI0734260T1 (en) 1999-08-31
RU2146141C1 (ru) 2000-03-10
DZ1835A1 (fr) 2002-02-17
EP0734260A1 (en) 1996-10-02
FI962445A (fi) 1996-06-12
CA2274389A1 (en) 1995-06-22
NZ277790A (en) 1998-02-26
PL314980A1 (en) 1996-09-30
EP0734260B2 (en) 2008-07-09
HUT75880A (en) 1997-05-28
BR9408219A (pt) 1997-08-26
RO115413B1 (ro) 2000-02-28
FI962445A0 (fi) 1996-06-12
JP3037757B2 (ja) 2000-05-08
CA2214575A1 (en) 1995-06-22
SA94150373B1 (ar) 2006-05-27
SA94150373A (ar) 2005-12-03
CN1071116C (zh) 2001-09-19
AU1314595A (en) 1995-07-03
CA2274387A1 (en) 1995-06-22
ES2132610T5 (es) 2008-12-16
NO307366B1 (no) 2000-03-27
BG100648A (bg) 1997-02-28
IL111978A0 (en) 1995-03-15
UA42745C2 (uk) 2001-11-15
NO962547D0 (no) 1996-06-14
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
ES2132610T3 (es) 1999-08-16
BG62755B1 (bg) 2000-07-31
AP9400704A0 (en) 1995-01-31

Similar Documents

Publication Publication Date Title
HU9601665D0 (en) Paroxetine tablets and process to prepare them
NZ235242A (en) 1-cycloalkyl piperidines and pharmaceutical compositions
EP0434313A3 (en) Enhanced direct bond process and structure
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
GB2216386B (en) Canning process and composition
HU216713B (hu) Ciklusos acetálok és eljárás az előállításukra
GB9420539D0 (en) Process and composition
HUT71606A (en) Amino-ascorbic acid derivatives, halogen-ascorbic acid derivatives and process to prepare them
HUP9602470A3 (en) Tablets containing captopril and process for producing them
GB2282966B (en) A pharmaceutical composition having anti-decrepit action and a process for preparation thereof
GB2275922B (en) Bifilm process and plant
IL91973A0 (en) Tin organofluorides and process for their preparation
HUT59154A (en) Process for producing 6-methyl-19-norsteroids and pharmaceutical compositions comprising same
GB9004313D0 (en) Conversion composition and process
HUT71517A (en) Process to prepare (2-benzyloxy-6-nitrophenyl)-acetonitril
HU9303259D0 (en) New pharmaceutical composition and process for producing them
HU9403074D0 (en) Transdermal pharmaceutical compositions and process for producing them
HU9500156D0 (en) Pharmaceutical composition and process
HUT66861A (en) Lignane analogues and process to prepare them
GB9302509D0 (en) Pharmaceutical process
GB9326222D0 (en) Composition and process
HUT69389A (en) Amino-ciklohexane-derivatives and process for their production
GB8922866D0 (en) Pharmaceutical method and compositions
GB8922867D0 (en) Pharmaceutical method and compositions
GB8904434D0 (en) Conversion composition and process